Moreover, it was found that pathways in cancer were upregulated that involve the disruption of the ErbB, p-53-mediated apoptotic, and GSK3 signaling pathways, which are involved in DNA repair, cell growth, migration, differentiation, and metabolism (Yip and Papa, 2021). This evidence concerns the gene EGFR and cancer.